Total combined global risk assessment applied to pharmaceutical equivalence – A case study of ofloxacin medicines
Authors:
- Arthur M. CaffaroACArthur M. Caffaro
- Felipe R. LourençoFLFelipe R. Lourenço
- 24 August 2023
- journal article
- research article
- Published by Elsevier in Chemometrics and Intelligent Laboratory Systems
- Vol. 241
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2022/08406-5)
This publication has 20 references indexed in Scilit:
- Risk of false conformity decisions of multicomponent items controlled by correlated measurement results due to the sharing of analytical stepsTalanta, 2019
- Risk of a false decision on conformity of an environmental compartment due to measurement uncertainty of concentrations of two or more pollutantsChemosphere, 2018
- Using measurement uncertainty to assess the fitness for purpose of an HPLC analytical method in the pharmaceutical industryMeasurement, 2018
- Risk of false decision on conformity of a multicomponent material when test results of the components’ content are correlatedTalanta, 2017
- Conformity assessment of multicomponent materials or objects: Risk of false decisions due to measurement uncertainty – A case study of denatured alcoholsTalanta, 2017
- Measurement uncertainty of a UPLC stability indicating method for determination of linezolid in dosage formsMeasurement, 2015
- Rational development and validation of a new microbiological assay for linezolid and its measurement uncertaintyTalanta, 2014
- Uncertainty evaluation for determining linezolid in injectable solution by UV spectrophotometryMeasurement, 2013
- Using target measurement uncertainty to determine fitness for purposeAccreditation and Quality Assurance, 2012
- The estimation and use of measurement uncertainty for a drug substance test procedure validated according to USP Accreditation and Quality Assurance, 2011